Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
65
NMPA:65
Drug Approvals
Cisatracurium Besylate Injection
- Product Name
- 苯磺顺阿曲库铵注射液
- Approval Number
- 国药准字H20249354
- Approval Date
- Nov 15, 2024
NMPA
Cisatracurium Besylate Injection
- Product Name
- 苯磺顺阿曲库铵注射液
- Approval Number
- 国药准字H20249355
- Approval Date
- Nov 15, 2024
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20247265
- Approval Date
- Nov 4, 2024
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20234519
- Approval Date
- Nov 21, 2023
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20234471
- Approval Date
- Nov 14, 2023
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20234489
- Approval Date
- Nov 14, 2023
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20083700
- Approval Date
- Dec 8, 2022
NMPA
Bulleyaconitine A for Injection
- Product Name
- 凯瑶
- Approval Number
- 国药准字H20060972
- Approval Date
- Jan 29, 2021
NMPA
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20063427
- Approval Date
- Jan 29, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found